143 related articles for article (PubMed ID: 12589570)
1. Characterization of calcium binding properties of lithostathine.
Lee BI; Mustafi D; Cho W; Nakagawa Y
J Biol Inorg Chem; 2003 Feb; 8(3):341-7. PubMed ID: 12589570
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Ca(2+)-binding sites in the kidney stone inhibitor glycoprotein nephrocalcin using vanadyl ions: different metal binding properties in strong and weak inhibitor proteins revealed by EPR and ENDOR.
Mustafi D; Nakagawa Y
Biochemistry; 1996 Nov; 35(47):14703-9. PubMed ID: 8942630
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of human lithostathine, the pancreatic inhibitor of stone formation.
Bertrand JA; Pignol D; Bernard JP; Verdier JM; Dagorn JC; Fontecilla-Camps JC
EMBO J; 1996 Jun; 15(11):2678-84. PubMed ID: 8654365
[TBL] [Abstract][Full Text] [Related]
4. An insight into the role of human pancreatic lithostathine.
Patard L; Lallemand JY; Stoven V
JOP; 2003 Mar; 4(2):92-103. PubMed ID: 12629266
[TBL] [Abstract][Full Text] [Related]
5. [Single amino acid substitutions in the Ca2+-binding site of recoverin.II.The unusual behavior of the protein upon the binding of calcium ions].
Uverskiĭ VN; Permiakov SE; Senin II; Cherskaia AM; Shul'ga-Morskoĭ SV; Zinchenko DV; Alekseev AM; Zargarov AA; Lipkin VM; Filippov PP; Permiakov EA
Bioorg Khim; 2000 Mar; 26(3):173-8. PubMed ID: 10816814
[TBL] [Abstract][Full Text] [Related]
6. [Pancreatic lithogenesis].
Sarles H
Ann Gastroenterol Hepatol (Paris); 1986; 22(1):37-40. PubMed ID: 3963739
[TBL] [Abstract][Full Text] [Related]
7. [Pancreatic lithostathine inhibitor of calcium carbonate precipitation: structure-function relationship].
Bernard JP; Takacs T; de Reggi M; Sarles H; Dagorn JC
Nephrologie; 1993; 14(6):257-9. PubMed ID: 8145882
[TBL] [Abstract][Full Text] [Related]
8. Equilibrium dialysis measurements of the Ca2+-binding properties of recombinant radish vacuolar Ca2+-binding protein expressed in Escherichia coli.
Yuasa K; Maeshima M
Biosci Biotechnol Biochem; 2002 Nov; 66(11):2382-7. PubMed ID: 12506976
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for the evolutionary inactivation of Ca2+ binding to synaptotagmin 4.
Dai H; Shin OH; Machius M; Tomchick DR; Südhof TC; Rizo J
Nat Struct Mol Biol; 2004 Sep; 11(9):844-9. PubMed ID: 15311271
[TBL] [Abstract][Full Text] [Related]
10. The W105G and W99G sorcin mutants demonstrate the role of the D helix in the Ca(2+)-dependent interaction with annexin VII and the cardiac ryanodine receptor.
Colotti G; Zamparelli C; Verzili D; Mella M; Loughrey CM; Smith GL; Chiancone E
Biochemistry; 2006 Oct; 45(41):12519-29. PubMed ID: 17029407
[TBL] [Abstract][Full Text] [Related]
11. Characterization of calcium-binding sites in the kidney stone inhibitor glycoprotein nephrocalcin with vanadyl ions: electron paramagnetic resonance and electron nuclear double resonance spectroscopy.
Mustafi D; Nakagawa Y
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11323-7. PubMed ID: 7972057
[TBL] [Abstract][Full Text] [Related]
12. Bacterial expression and characterization of a novel, soluble, calcium-binding, and calcium-activated human nucleotidase.
Murphy DM; Ivanenkov VV; Kirley TL
Biochemistry; 2003 Mar; 42(8):2412-21. PubMed ID: 12600208
[TBL] [Abstract][Full Text] [Related]
13. Structure and calcium-binding activity of LipL32, the major surface antigen of pathogenic Leptospira sp.
Hauk P; Guzzo CR; Roman Ramos H; Ho PL; Farah CS
J Mol Biol; 2009 Jul; 390(4):722-36. PubMed ID: 19477185
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic stone protein (lithostathine), a physiologically relevant pancreatic calcium carbonate crystal inhibitor?
Bimmler D; Graf R; Scheele GA; Frick TW
J Biol Chem; 1997 Jan; 272(5):3073-82. PubMed ID: 9006958
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of ALG-2. A novel apoptosis-linked Ca(2+)-binding protein.
Zhang M; Lo KW
Methods Mol Biol; 2002; 172():235-42. PubMed ID: 11833351
[No Abstract] [Full Text] [Related]
16. Effects of Zn(2+), Ca(2+), and Mg(2+) on the structure of Zn(7)metallothionein-3: evidence for an additional zinc binding site.
Meloni G; Polanski T; Braun O; Vasák M
Biochemistry; 2009 Jun; 48(24):5700-7. PubMed ID: 19425569
[TBL] [Abstract][Full Text] [Related]
17. PAP I interacts with itself, PAP II, PAP III, and lithostathine/regIalpha.
Bödeker H; Keim V; Fiedler F; Dagorn JC; Iovanna JL
Mol Cell Biol Res Commun; 1999; 2(3):150-4. PubMed ID: 10662590
[TBL] [Abstract][Full Text] [Related]
18. Axial ligand coordination in sterically strained vanadyl porphyrins: synthesis, structure, and properties.
Ghosh SK; Patra R; Rath SP
Inorg Chem; 2008 Nov; 47(21):9848-56. PubMed ID: 18823111
[TBL] [Abstract][Full Text] [Related]
19. Calcium regulation of inositol 1,4,5-trisphosphate receptors.
Joseph SK; Brownell S; Khan MT
Cell Calcium; 2005 Dec; 38(6):539-46. PubMed ID: 16198415
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the redox and metal binding activity of BsSco, a protein implicated in the assembly of cytochrome c oxidase.
Imriskova-Sosova I; Andrews D; Yam K; Davidson D; Yachnin B; Hill BC
Biochemistry; 2005 Dec; 44(51):16949-56. PubMed ID: 16363808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
